Results

Total Results: over 10,000 records

Showing results for "risk".

341. Improving the Safety of Diagnosis and Therapy in the Inpatient Setting | Agency for Healthcare Research and Quality
     healthcare411.ahrq.gov/patient-safety/resources/learning-lab/improving-safety-diagnosis-long-desc.html
     February 01, 2024 - In this risk score, X n represents baseline risk factors and in-hospital clinical factors, as well as … The high-risk cohorts included cases of patients who were transferred to the ICU after 24 hours, died … with preimplementation period (16.5 vs. 20.9, OR 0.75 [95% CI 0.43-1.29], p=0.29), or a 25 percent relative … risk reduction in overall DE. 1 In postimplementation analysis, researchers found that relative risk … reductions in DE were greater in patients in the high-risk cohort.

342. Improving the Safety of Diagnosis and Therapy in the Inpatient Setting | Agency for Healthcare Research and Quality
     cahps.ahrq.gov/patient-safety/resources/learning-lab/improving-safety-diagnosis-long-desc.html
     February 01, 2024 - In this risk score, X n represents baseline risk factors and in-hospital clinical factors, as well as … The high-risk cohorts included cases of patients who were transferred to the ICU after 24 hours, died … with preimplementation period (16.5 vs. 20.9, OR 0.75 [95% CI 0.43-1.29], p=0.29), or a 25 percent relative … risk reduction in overall DE. 1 In postimplementation analysis, researchers found that relative risk … reductions in DE were greater in patients in the high-risk cohort.

343. Improving the Safety of Diagnosis and Therapy in the Inpatient Setting | Agency for Healthcare Research and Quality
     monahrq.ahrq.gov/patient-safety/resources/learning-lab/improving-safety-diagnosis-long-desc.html
     February 01, 2024 - In this risk score, X n represents baseline risk factors and in-hospital clinical factors, as well as … The high-risk cohorts included cases of patients who were transferred to the ICU after 24 hours, died … with preimplementation period (16.5 vs. 20.9, OR 0.75 [95% CI 0.43-1.29], p=0.29), or a 25 percent relative … risk reduction in overall DE. 1 In postimplementation analysis, researchers found that relative risk … reductions in DE were greater in patients in the high-risk cohort.

344. Improving the Safety of Diagnosis and Therapy in the Inpatient Setting | Agency for Healthcare Research and Quality
     ce.effectivehealthcare.ahrq.gov/patient-safety/resources/learning-lab/improving-safety-diagnosis-long-desc.html
     February 01, 2024 - In this risk score, X n represents baseline risk factors and in-hospital clinical factors, as well as … The high-risk cohorts included cases of patients who were transferred to the ICU after 24 hours, died … with preimplementation period (16.5 vs. 20.9, OR 0.75 [95% CI 0.43-1.29], p=0.29), or a 25 percent relative … risk reduction in overall DE. 1 In postimplementation analysis, researchers found that relative risk … reductions in DE were greater in patients in the high-risk cohort.

345. Draft Recommendation: Prevention of Child Maltreatment: Primary Care Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/primary-care-interventions-child-maltreatment
     August 29, 2023 - intervention, there were no group differences between intervention and control groups (3.9% vs. 3.5%; relative … yielded inconsistent results. 1 In one trial, there were no differences reported in physical abuse (relative … risk, 1.45 [95% CI, 0.58 to 3.62]) or neglect (relative risk, 2.79 [95% CI, 0.98 to 7.91) between the … , risks of further harm to the child, dissolution of families, or worsening inequities. 1 Two trials … or legal risks related to Child Protective Services) and to engagement in preventive interventions (

346. Evidence Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
     June 11, 2019 - (11 trials; relative risk [RR], 0.46 [95% CI, 0.33-0.66]; I 2 = 67%; absolute risk reduction [ARD] … Data Synthesis Meta-analysis was conducted to calculate pooled relative risks (RRs) for effects of … 0.54 (0.37-0.79) 72 Abbreviations: NA, not applicable; PrEP, preexposure prophylaxis; RR, relative … 2.10) 0 Abbreviations: MSM, men who have sex with men; PrEP, preexposure prophylaxis; RR, relative … difference; ARR, adjusted relative risk; AUROC, area under the receiver operating characteristics curve

347. Archived: Evidence Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
     June 11, 2019 - (11 trials; relative risk [RR], 0.46 [95% CI, 0.33-0.66]; I 2 = 67%; absolute risk reduction [ARD] … Data Synthesis Meta-analysis was conducted to calculate pooled relative risks (RRs) for effects of … 0.54 (0.37-0.79) 72 Abbreviations: NA, not applicable; PrEP, preexposure prophylaxis; RR, relative … 2.10) 0 Abbreviations: MSM, men who have sex with men; PrEP, preexposure prophylaxis; RR, relative … difference; ARR, adjusted relative risk; AUROC, area under the receiver operating characteristics curve

348. Routine Vitamin Supplementation to Prevent Cancer: Update of the Evidence from Randomized Controlled Trials 1999–2002 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/dKPBY-h5PbactdPHgVHbz_
     June 01, 2003 - Based on the cumulative incidence of colorectal cancer over the study period, the relative risk among … These studies did not examine the independent effect of supplementation on cancer risks. … The relative risk for lung cancer when comparing the highest quintile of baseline serum alpha-tocopherol … Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and … nonmelanoma skin cancer; P, probability; PHS, Physicians Health Study; RCT, randomized controlled trial; RR, relative

349. Osteoarthritis-Pain Clinician (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/shareddecisionmaking/workshop/osteoarthritis-pain_clinician.pdf
     January 01, 2012 - NSAIDs; however, differences in GI adverse effects must be balanced with associated cardiovascular (CV) risks … � Concomitant use of low-dose aspirin eliminated the GI benefits of selective NSAIDs, resulting in risks … analgesic interventions in real-world settings. �� More evidence is needed to assess the comparative CV risks … and GI benefits associated with different COX-2 selective NSAIDs. �� The risks associated with selective … approves a pharmaceutical-grade glucosamine. �� More evidence is needed to evaluate the comparative risks

350. Benefits and Harms of Routine Preoperative Testing: Comparative Effectiveness | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/preoperative-testing/research
     December 01, 2019 - complete blood count, and/or a basic metabolic panel did not affect procedure cancellations (2 RCTs, relative … risks [RRs] of 1.00 or 0.97), and there was no clinically important difference for total complications … They also mostly had high risk of bias due to lack of adjustment for patient and clinician factors, making … the cataract surgery studies are not reliably applicable to other patients undergoing other higher risk … the benefits and harms of routine preoperative testing in specific groups of patients with different risk

351. Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/crPsNJ_R5SFnJhuT2CEpkr
     March 01, 2019 - Warfarin (mean, 1.5 years) was associated with a reduced risk of ischemic stroke (relative risk [RR], … For KQ4 and KQ5, relative risks (RRs) and 95% CIs were calculated for all-cause mortality, cardiovascular-related … Relative Risk of All-Cause Mortality and Selected Health Outcomes for Warfarin Compared With Controls … Relative Risk of Major Bleeding, Major Extracranial Bleeding, and Intracranial Hemorrhage for Warfarin … Compared With Controls (KQ5) Weight, % Favors Warfarin Favors Control Relative Risk (95% CI) Mean

352. The SHARE Approach—Essential Steps of Shared Decisionmaking: Expanded Reference Guide with Sample Conversation Starters | Agency for Healthcare Research and Quality
     www.ahrq.gov/health-literacy/professional-training/shared-decision/tool/resource-2.html
     September 01, 2020 - It is critical to present both the benefits and risks of each option. … Communicate numbers in a way that your patient can understand Numbers can be a big part of discussing risk … Tips Avoid descriptive terms (such as "low risk"). Instead, provide estimated numbers. … Whenever possible, use absolute numbers—not relative risks. … Numeracy skill and the communication, comprehension, and use of risk-benefit information.

353. Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/wBcZfBcVp8N3-cyT3Peysv
     April 01, 2016 - In analyses of all doses, aspirin reduced the risk for nonfatal myocardial infarction (MI) (relative … tiplying the sample size of the control group by the mean follow-up years), thereby assuming constant risks … risks (RRs) from the included CVD pri- mary prevention trials evaluating aspirin doses of 100 mg or … is higher than that for the aver- age population and high enough to outweigh the seri- ous bleeding risks … Bleeding risks with aspirin use for primary prevention in adults: a systematic evidence review for the

354. Recommendation: Hypertensive Disorders of Pregnancy: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertensive-disorders-pregnancy-screening
     September 19, 2023 - factor. 34 Clinicians should also be aware of the risks of poor health outcomes for populations at … risk. … −1.58 days [95% CI, −8.10 to 4.94 days]), number of hypertensive disorders of pregnancy diagnoses (relative … of labor for any reason and for reasons related to hypertension or fetal distress. 1 , 38 , 41 , 42 Relative … risks for all these outcomes were close to or less than 1, with no statistically significant differences

355. CHIPRA 233: Section 3, Table 2, FDA Pregnancy Category Rating (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-hrob-section-3-table-2.pdf
     August 08, 2018 - Category Explanation Category A Adequate and well-controlled studies have failed to demonstrate a risk … Category B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks … based on adverse reaction data from investigational or marketing experience, and the risks involved

356. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/47150/psn-pdf
     November 21, 2018 - hospital mortality surveillance system that generates monthly mortality alerts) and trends in the relative … risk of mortality across National Health Service hospital trusts. … On average, mortality risk decreased after a trust received a mortality alert. … A past PSNet perspective discussed the use of risk-adjusted mortality as part of a safety measurement … report-mid-staffordshire-nhs-foundation-trust-public-inquiry https://psnet.ahrq.gov/perspective/where-does-risk-adjusted-mortality-fit-safety-measurement-program

357. Final Evidence Summary: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary51/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     April 08, 2014 - low-dose aspirin use (relative risk [RR], 0.81 [95% CI, 0.65 to 1.01]; I 2 = 0%), but the result was … Figure 1 is a forest plot depicting the relative risk for preterm birth after aspirin prophylaxis and … Figure 3 is a forest plot depicting the relative risk for preeclampsia after aspirin prophylaxis. … Appendix Figure 3 is a forest plot depicting the relative risk for perinatal mortality after aspirin … Appendix Figure 5 is a forest plot depicting the relative risk for intracranial fetal bleeding after

358. Archived: Final Evidence Summary: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary51/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
     April 08, 2014 - low-dose aspirin use (relative risk [RR], 0.81 [95% CI, 0.65 to 1.01]; I 2 = 0%), but the result was … Figure 1 is a forest plot depicting the relative risk for preterm birth after aspirin prophylaxis and … Figure 3 is a forest plot depicting the relative risk for preeclampsia after aspirin prophylaxis. … Appendix Figure 3 is a forest plot depicting the relative risk for perinatal mortality after aspirin … Appendix Figure 5 is a forest plot depicting the relative risk for intracranial fetal bleeding after

359. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/thromboembolism-update/research-2017
     January 01, 2021 - In THR, LMWH has lower VTE and adverse event risks than unfractionated heparin; LMWH and aspirin have … similar risks of VTE and major bleeding; direct thrombin inhibitors (DTI) have lower DVT risk than LMWH … LMWH and aspirin have similar risks of total PE, symptomatic DVT, and major bleeding (low SoE). … Longer duration LMWH has lower risk of various VTE outcome risks (low to high SoE). … In THR, LMWH has lower VTE and adverse event risks than UFH, LMWH and aspirin have similar risks of VTE

360. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
     March 13, 2012 - 2: Do specifics of OC use (e.g., dose/formulation, age at initiation, duration of use) affect the relative … age, family history of breast and ovarian cancer, BRCA1/BRCA2 mutation status, parity) affect the relative … and relative risk (or relative risk reduction) for that outcome in OC users to generate estimates of … risk. … Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.